Cancer News and Research

Latest Cancer News and Research

Potential new test for breast cancer patients for abnormal reactions to radiotherapy

Medical scientists at the University of Leicester have announced a potentially unique advance in breast cancer research by identifying two genes associated with adverse reaction to cancer treatment.

20 Apr 2007

Why cisplatin kills breast cancer cells when other drugs fail

The cancerous cells of some individuals with breast cancer lack expression of two cell surface proteins, the estrogen and progesterone receptors, and do not express increased amounts of HER2.

20 Apr 2007

Treating berries with alcohol leads to an increase in antioxidant capacity

Strawberries are good for you, but serving them in daiquiri form may make them even healthier, scientists show.

20 Apr 2007

Smoking associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy

A history of smoking is associated with an increased risk of metastatic disease in patients treated with radiotherapy (XRT) for prostate cancer (CaP), according to a report in the online version of the BJU International.

20 Apr 2007

Response to paper on ovarian cancer in the Million Women study

The Million Women Study (MWS) has reported new data on the risk of ovarian cancer in postmenopausal hormone users(1).

20 Apr 2007

Childhood sarcoma increases risk of blood clots

Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, have determined that children and young adults with a form of cancer called sarcoma are at increased risk of having a thromboembolic event (TE) in their veins.

20 Apr 2007

Steven Piantadosi named as first Director of Samuel Oschin Comprehensive Cancer Institute

Internationally renowned cancer researcher Steven Piantadosi, M.D., Ph.D, has been named director of the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center.

20 Apr 2007

Study evaluates CaP risk among finasteride users

Current medical management for BPH includes alpha-blockers and 5- reductase inhibitors.

20 Apr 2007

Prostate cancer treatment decisions can be complicated

For many men with early-stage prostate cancer, sorting out the treatment options can be overwhelming.

20 Apr 2007

Novel targeted therapy effectively treats acute leukemia

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found that a novel targeted therapy effectively treats acute leukemia in animal models by preventing cancer cells from being purged of damaged proteins.

20 Apr 2007

New research may help identify patients most likely to benefit from cisplatin treatment

Researchers at the Massachusetts General Hospital (MGH) Cancer Center have identified a subgroup of hard-to-treat breast cancers that may be sensitive to the drug cisplatin, rarely used in the treatment of breast tumors.

20 Apr 2007

Long-term survival probability in men with clinically localized prostate cancer

Randomized studies comparing conservative therapy to definitive therapy in men with prostate cancer (CaP) are underway, but not yet available.

20 Apr 2007

Indevus Pharmaceuticals submits supplemental NDA for VALSTAR

Indevus Pharmaceuticals has announced that it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking approval to reintroduce VALSTAR in the United States.

20 Apr 2007

International Menopause Society reaction to report on breast cancer

A special report in the April 19 issue of the New England Journal of Medicine [1] brings initial analysis of data from the National Cancer Institute's Surveillance, Epidemiology and End Result (SEER) registries, showing that the incidence of breast cancer in women in the US fell by 6.7% in 2003, and stayed at the same level in 2004.

20 Apr 2007

College-age students who drink heavily may increase their risk for future heart disease

In a small study, Minnesota researchers found that a group of college students who drank heavily had higher levels of C-reactive protein (CRP), a blood marker for inflammation that can increase the risk for heart disease.

20 Apr 2007

Bill broadening prescribing rights to psychologists unsafe

Setting the stage for another legislative battle that puts mental health patients in the middle, a bill seeking to give licensed psychologists prescribing privileges for dangerous medications is scheduled to be heard on April 23, 2007 in the Senate Business, Professions and Economic Development Committee.

20 Apr 2007

Access Pharmaceuticals and Somanta Pharmaceuticals sign merger agreement

Access Pharmaceuticals and Somanta Pharmaceuticals have announced that they have signed a definitive merger agreement by which Access will acquire Somanta.

20 Apr 2007

Viventia Biotech announces results of Proxinium antibody in combinaton with chemotherapy and radiation

Viventia Biotech has announced results of in vitro cytotoxicity and in vivo pharmacokinetic studies conducted to evaluate the potential for combining its phase III anti-cancer antibody therapeutic, Proxinium, with first-line standard of care therapy for squamous cell carcinoma of the head & neck (SCCHN).

19 Apr 2007

Understanding personal genetic risk for familial breast cancer eases anxieties

Services that help women understand the way that their inherited genetic make-up influences their risk of getting breast cancer ease distress and decrease their levels of cancer worry.

19 Apr 2007

Chinese herbs may help women with breast cancer

Using Chinese herbs either alone or in conjunction with chemotherapy may help protect a breast cancer patient’s bone marrow and immune system, as well as improving the woman’s overall quality of life.

19 Apr 2007

Cancer News and Research

Latest Cancer News and Research

Potential new test for breast cancer patients for abnormal reactions to radiotherapy

Why cisplatin kills breast cancer cells when other drugs fail

Treating berries with alcohol leads to an increase in antioxidant capacity

Smoking associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy

Response to paper on ovarian cancer in the Million Women study

Childhood sarcoma increases risk of blood clots

Steven Piantadosi named as first Director of Samuel Oschin Comprehensive Cancer Institute

Study evaluates CaP risk among finasteride users

Prostate cancer treatment decisions can be complicated

Novel targeted therapy effectively treats acute leukemia

New research may help identify patients most likely to benefit from cisplatin treatment

Long-term survival probability in men with clinically localized prostate cancer

Indevus Pharmaceuticals submits supplemental NDA for VALSTAR

International Menopause Society reaction to report on breast cancer

College-age students who drink heavily may increase their risk for future heart disease

Bill broadening prescribing rights to psychologists unsafe

Access Pharmaceuticals and Somanta Pharmaceuticals sign merger agreement

Viventia Biotech announces results of Proxinium antibody in combinaton with chemotherapy and radiation

Understanding personal genetic risk for familial breast cancer eases anxieties

Chinese herbs may help women with breast cancer

Understanding the DNA Damage Response in Innate Immunity eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in